HLA inherence as a potential parameter in checkpoint inhibitor-associated autoimmune adverse event assessment. - Gandarillas S; Newland ES; Toppmeyer D; Stephenson R; Denzin L; Dasgeb B (Frontiers in medicine, 2024)